Literature DB >> 19307751

Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.

Seung-Ha Yang1, Min-Jung Park, Il-Hee Yoon, Su-Young Kim, So-Hee Hong, Jin-Young Shin, Hye-Young Nam, Yong-Hee Kim, Bongi Kim, Chung-Gyu Park.   

Abstract

Mesenchymal stem cells (MSCs) can inhibit T cell proliferation; however, the underlying mechanisms are not clear. In this study, we investigated the mechanisms of the immunoregulatory activity of MSCs on T cells. Irradiated MSCs co-cultured with either na?ve or pre-activated T cells in a mixed lymphocyte reaction (MLR) significantly suppressed T cell proliferation in a dose-dependent manner, irrespective of allogeneic disparity between responders and MSCs. Transwell assays revealed that the suppressive effect was primarily mediated by soluble factors that induced apoptosis. Splenocytes stimulated with alloantigen in the presence of the MSC culture supernatant (CS) produced a significant amount of IL-10, which was attributed to an increase in the number of IL-10 secreting cells, confirmed by an ELISPOT assay. The blockade of IL-10 and IL-10 receptor interaction by anti-IL-10 or anti-IL-10-receptor antibodies abrogated the suppressive capacity of MSC CS, indicating that IL-10 plays a major role in the suppression of T cell proliferation. The addition of 1-methyl-DL-tryptophan (1-MT), an indoleamine 2,3-dioxygenase (IDO) inhibitor, also restored the proliferative capacity of T cells. In conclusion, we demonstrated that soluble mediators from culture supernatant of MSCs could suppress the proliferation of both naive and pre-activated T cells in which IL-10 and IDO play important roles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307751      PMCID: PMC2701980          DOI: 10.3858/emm.2009.41.5.035

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  37 in total

1.  Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells.

Authors:  M Reyes; T Lund; T Lenvik; D Aguiar; L Koodie; C M Verfaillie
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

2.  When ligand becomes receptor--tolerance via B7 signaling on DCs.

Authors:  Erik B Finger; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

3.  Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens.

Authors:  Julius A Potian; Hana Aviv; Nicholas M Ponzio; Jonathan S Harrison; Pranela Rameshwar
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

4.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

Authors:  Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo D Longoni; Paola Matteucci; Salvatore Grisanti; Alessandro M Gianni
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

5.  IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis.

Authors:  A Ayala; C S Chung; G Y Song; I H Chaudry
Journal:  Cytokine       Date:  2001-04-07       Impact factor: 3.861

6.  Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.

Authors:  William T Tse; John D Pendleton; Wendy M Beyer; Matthew C Egalka; Eva C Guinan
Journal:  Transplantation       Date:  2003-02-15       Impact factor: 4.939

7.  Localized interleukin-10 gene transfer induces apoptosis of alloreactive T cells via FAS/FASL pathway, improves function, and prolongs survival of cardiac allograft.

Authors:  Kiyohiro Oshima; Luyi Sen; Guanggen Cui; Thomas Tung; Benjamin M Sacks; Anthony Arellano-Kruse; Hillel Laks
Journal:  Transplantation       Date:  2002-04-15       Impact factor: 4.939

8.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

Authors:  Mauro Krampera; Sarah Glennie; Julian Dyson; Diane Scott; Ruthline Laylor; Elizabeth Simpson; Francesco Dazzi
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

9.  Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.

Authors:  Peter Terness; Thomas M Bauer; Lars Röse; Christoph Dufter; Andrea Watzlik; Helmut Simon; Gerhard Opelz
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

10.  Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

Authors:  Guido Frumento; Rita Rotondo; Michela Tonetti; Gianluca Damonte; Umberto Benatti; Giovanni Battista Ferrara
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  76 in total

1.  Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.

Authors:  Won Sik Lee; Yasuhiro Suzuki; Scott S Graves; Mineo Iwata; G M Venkataraman; Marco Mielcarek; Laura J Peterson; Susumu Ikehara; Beverly Torok-Storb; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-10       Impact factor: 5.742

Review 2.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

Review 3.  Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro.

Authors:  Aleksandra Gornostaeva; Elena Andreeva; Ludmila Buravkova
Journal:  Cytotechnology       Date:  2015-08-13       Impact factor: 2.058

4.  Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment.

Authors:  Jaime F Modiano; Beth A Lindborg; Ron T McElmurry; Mitzi Lewellen; Colleen L Forster; Edward A Zamora; Jerome Schaack; Donald Bellgrau; Timothy D O'Brien; Jakub Tolar
Journal:  Cancer Immunol Immunother       Date:  2015-08-07       Impact factor: 6.968

5.  Cord blood mesenchymal stem cells propel human dendritic cells to an intermediate maturation state and boost interleukin-12 production by mature dendritic cells.

Authors:  Lieke C J van den Berk; Helene Roelofs; Tonnie Huijs; Kim G C Siebers-Vermeulen; Reinier A Raymakers; Gesine Kögler; Carl G Figdor; Ruurd Torensma
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

Review 6.  Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint.

Authors:  Niamh Fahy; Eric Farrell; Thomas Ritter; Aideen E Ryan; J Mary Murphy
Journal:  Tissue Eng Part B Rev       Date:  2014-08-04       Impact factor: 6.389

Review 7.  Activity of mesenchymal stem cells in therapies for chronic skin wound healing.

Authors:  Austin Nuschke
Journal:  Organogenesis       Date:  2013-12-10       Impact factor: 2.500

8.  Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells.

Authors:  Jiang Li; Oleg Andreyev; Man Chen; Michael Marco; Hayato Iwase; Cassandra Long; David Ayares; Zhongyang Shen; David K C Cooper; Mohamed B Ezzelarab
Journal:  Cell Immunol       Date:  2013-08-29       Impact factor: 4.868

Review 9.  Stem cell paracrine actions and tissue regeneration.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

Review 10.  The role of recipient T cells in mesenchymal stem cell-based tissue regeneration.

Authors:  Yi Liu; Songlin Wang; Songtao Shi
Journal:  Int J Biochem Cell Biol       Date:  2012-08-09       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.